Delivery Order SPE2DB20D6037-SPE2DB22FD0KU
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $31,745.75 contract, which has no set-aside designation, is for the delivery of Activase 100 mg vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,793.67 firm-fixed-price contract is for the delivery of Activase 50 mg vials, a prescription medication. The contract has an ultimate completion date of November 4, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which covers a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,047.45 firm fixed-price contract is for the supply of ACTIVASE 100 MG VIALS, a pharmaceutical product, with a period of performance through September 3, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $9,549.69, is for the delivery of 50 mg vials of the medication ACTIVASE. This is a recurring medical supply contract to support the needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under contract SPE2DB20D9637. The $6,366.46 award is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a completion date of August 19, 2024. DMS Pharmaceutical Group is a key supplier of a wide range of medications, including branded and generic prescription drugs, biologics, and medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,594.91, is for the delivery of ACTIVASE 50 MG VIALS and has an ultimate completion date of April 5, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a potential value of up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,183.23 order is for 50 mg vials of the medication Activase, with a period of performance through July 15, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,253.96, is for the delivery of Activase 50 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $38,094.90 and has a firm fixed-price pricing type. The contract provides for the delivery of Activase 100 mg vials, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc....
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $3,183.23 for the supply of ACTIVASE 50 MG VIALS. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), under the Medical Supply Chain program. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB22FD0KUDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,847.06, is for the delivery of the pharmaceutical product Activase 100 mg vials. It is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 9/27/22 |